Suchergebnisse - "Huchot, Eric"

PubPharm (13)

1

Resected EGFR-mutated non-small-cell lung cancers : incidence and outcomes in a European population (GFPC Exerpos Study)

enthalten in: Therapeutic advances in medical oncology | 2024

von Auliac, J. | Thomas, P. | Bylicki, O. | +16

2

Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)

enthalten in: Targeted oncology | 2023

von Dhamelincourt, E. | Descourt, R. | Rousseau-Bussac, G. | +15

3

Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)

enthalten in: Targeted oncology | 2023

von Dhamelincourt, E. | Descourt, R. | Rousseau-Bussac, G. | +15

4

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer : GFPC 03-18 Study

enthalten in: Targeted oncology | 2023

von Babey, H. | Jamme, P. | Curcio, H. | +12

5

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study

enthalten in: Targeted oncology | 2023

von Babey, H. | Jamme, P. | Curcio, H. | +12

6

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study

enthalten in: Targeted oncology | 2023

von Babey, H. | Jamme, P. | Curcio, H. | +12

7

Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Justeau, G. | Huchot, E. | Simonneau, Y. | +15

8

Brief Report : First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1 ≥50% (GFPC 01-20 Study)

enthalten in: Clinical lung cancer | 2022

von Guisier, F. | Descourt, R. | Babey, H. | +7

9

Molecular profile of non-small cell lung cancer in reunion Island

enthalten in: Respiratory medicine and research | 2022

von Moreau, D. | Huchot, E. | Foch, E. | +4

10

Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting : GFPC 01-2019

enthalten in: Cancers | 2020

von Auliac, J. | Bayle, S. | Do, P. | +10